HRP20230274T1 - Kemijski spojevi - Google Patents
Kemijski spojevi Download PDFInfo
- Publication number
- HRP20230274T1 HRP20230274T1 HRP20230274TT HRP20230274T HRP20230274T1 HR P20230274 T1 HRP20230274 T1 HR P20230274T1 HR P20230274T T HRP20230274T T HR P20230274TT HR P20230274 T HRP20230274 T HR P20230274T HR P20230274 T1 HRP20230274 T1 HR P20230274T1
- Authority
- HR
- Croatia
- Prior art keywords
- pharmaceutical preparation
- viral infection
- compound
- pharmaceutically acceptable
- chemical compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 7
- 208000036142 Viral infection Diseases 0.000 claims 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims 4
- 230000009385 viral infection Effects 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
Claims (6)
1. Spoj odabran između:
[image]
,
ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema zahtjevu 1 čija je struktura:
[image]
, ili njegova farmaceutski prihvatljiva sol.
3. Farmaceutski pripravak koji sadrži farmaceutski prihvatljiv razrjeđivač i terapeutski učinkovitu količinu spoja prema zahtjevu 1 ili 2.
4. Spoj prema zahtjevu 1 ili 2, ili farmaceutski pripravak prema zahtjevu 3, za uporabu u terapiji.
5. Spoj prema zahtjevu 1 ili 2, ili farmaceutski pripravak prema zahtjevu 3, za uporabu u liječenju virusne infekcije.
6. Spoj ili farmaceutski pripravak prema zahtjevu 5 za uporabu u liječenju virusne infekcije, naznačen time što je virusna infekcija hepatitis B virusna infekcija.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568633P | 2017-10-05 | 2017-10-05 | |
| US201762570509P | 2017-10-10 | 2017-10-10 | |
| US201862681146P | 2018-06-06 | 2018-06-06 | |
| US201862683859P | 2018-06-12 | 2018-06-12 | |
| PCT/IB2018/057767 WO2019069293A1 (en) | 2017-10-05 | 2018-10-05 | CHEMICAL COMPOUNDS |
| EP18795809.5A EP3692040B1 (en) | 2017-10-05 | 2018-10-05 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20230274T1 true HRP20230274T1 (hr) | 2023-04-28 |
Family
ID=64049476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20230274TT HRP20230274T1 (hr) | 2017-10-05 | 2018-10-05 | Kemijski spojevi |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20200255428A1 (hr) |
| EP (2) | EP3692040B1 (hr) |
| JP (1) | JP7248665B2 (hr) |
| KR (1) | KR20200065024A (hr) |
| CN (2) | CN116942663A (hr) |
| AU (2) | AU2018344926A1 (hr) |
| BR (1) | BR112020006456A2 (hr) |
| CA (1) | CA3078312A1 (hr) |
| CL (1) | CL2020000912A1 (hr) |
| CO (1) | CO2020004202A2 (hr) |
| DK (1) | DK3692040T3 (hr) |
| ES (1) | ES2940263T3 (hr) |
| FI (1) | FI3692040T3 (hr) |
| HR (1) | HRP20230274T1 (hr) |
| HU (1) | HUE061380T2 (hr) |
| IL (1) | IL273769A (hr) |
| LT (1) | LT3692040T (hr) |
| MX (1) | MX2020003382A (hr) |
| PH (1) | PH12020550145A1 (hr) |
| PL (1) | PL3692040T3 (hr) |
| PT (1) | PT3692040T (hr) |
| RS (1) | RS64043B1 (hr) |
| SG (2) | SG10202111648YA (hr) |
| SI (1) | SI3692040T1 (hr) |
| WO (1) | WO2019069293A1 (hr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016183266A1 (en) | 2015-05-13 | 2016-11-17 | Enanta Pharmaceuticals, Inc. | Ehpatitis b antiviral agents |
| KR102398439B1 (ko) | 2016-03-07 | 2022-05-16 | 이난타 파마슈티칼스, 인코포레이티드 | B형 간염 항바이러스제 |
| AR112481A1 (es) | 2017-08-28 | 2019-10-30 | Enanta Pharm Inc | Agentes antivirales contra la hepatitis b |
| WO2019143902A2 (en) | 2018-01-22 | 2019-07-25 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| US10729688B2 (en) | 2018-03-29 | 2020-08-04 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| WO2019246427A1 (en) * | 2018-06-22 | 2019-12-26 | Arbutus Biopharma Corporation | Crystalline forms of pyridinone-containing tricyclic compounds and methods of preparing and using same |
| KR20210065965A (ko) | 2018-09-21 | 2021-06-04 | 이난타 파마슈티칼스, 인코포레이티드 | 항바이러스제로서 작용화된 헤테로사이클 |
| US11447498B2 (en) | 2018-09-30 | 2022-09-20 | Sunshine Lake Pharma Co., Ltd. | Fused tetracyclic compounds and uses thereof in medicine |
| CA3119973A1 (en) | 2018-11-21 | 2020-05-28 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| CN111217811B (zh) * | 2018-11-26 | 2024-01-16 | 广东东阳光药业股份有限公司 | 稠合三环类化合物及其在药物中的应用 |
| TW202104214A (zh) | 2019-04-05 | 2021-02-01 | 英商葛蘭素史密斯克藍智慧財產發展有限公司 | 化合物 |
| US11236111B2 (en) | 2019-06-03 | 2022-02-01 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| WO2020247575A1 (en) | 2019-06-04 | 2020-12-10 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
| WO2020247561A1 (en) | 2019-06-04 | 2020-12-10 | Enanta Pharmaceuticals, Inc, | Hepatitis b antiviral agents |
| US11738019B2 (en) | 2019-07-11 | 2023-08-29 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| WO2021055425A2 (en) | 2019-09-17 | 2021-03-25 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| US11802125B2 (en) | 2020-03-16 | 2023-10-31 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| CN113173911A (zh) * | 2021-04-20 | 2021-07-27 | 梯尔希（南京）药物研发有限公司 | 吡虫啉代谢物5-羟基吡虫啉的合成方法 |
| WO2023144750A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Intellectual Property Development Limited | Combination therapy for treating hepatitis b virus infections |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015212903A1 (en) * | 2014-01-30 | 2016-05-19 | F. Hoffmann-La Roche Ag | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection |
| RU2016146365A (ru) * | 2014-05-13 | 2018-06-19 | Ф. Хоффманн-Ля Рош Аг | Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b |
| US9637485B2 (en) * | 2014-11-03 | 2017-05-02 | Hoffmann-La Roche Inc. | 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection |
| EP3256471B1 (en) * | 2015-02-11 | 2018-12-12 | F. Hoffmann-La Roche AG | Novel 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection |
| WO2017108630A1 (en) * | 2015-12-21 | 2017-06-29 | F. Hoffmann-La Roche Ag | Combination therapy of an hbsag inhibitor and an hbv capsid assembly inhibitor |
| WO2018047109A1 (en) | 2016-09-09 | 2018-03-15 | Novartis Ag | Polycyclic pyridone compounds as antivirals |
| KR102522060B1 (ko) * | 2016-11-07 | 2023-04-14 | 아뷰터스 바이오파마 코포레이션 | 치환된 피리디논 함유 트리시클릭 화합물, 및 그의 사용 방법 |
| CN109369640B (zh) * | 2017-01-13 | 2020-03-27 | 苏州爱科百发生物医药技术有限公司 | 一种二氢异喹啉类化合物的制备方法 |
| CN108727378A (zh) | 2017-04-19 | 2018-11-02 | 银杏树药业(苏州)有限公司 | 新型异喹啉类化合物及其医药用途 |
-
2018
- 2018-10-05 CN CN202310780889.9A patent/CN116942663A/zh active Pending
- 2018-10-05 HR HRP20230274TT patent/HRP20230274T1/hr unknown
- 2018-10-05 EP EP18795809.5A patent/EP3692040B1/en active Active
- 2018-10-05 MX MX2020003382A patent/MX2020003382A/es unknown
- 2018-10-05 KR KR1020207012236A patent/KR20200065024A/ko not_active Application Discontinuation
- 2018-10-05 CN CN201880078910.8A patent/CN111433206B/zh active Active
- 2018-10-05 SI SI201830862T patent/SI3692040T1/sl unknown
- 2018-10-05 ES ES18795809T patent/ES2940263T3/es active Active
- 2018-10-05 JP JP2020519410A patent/JP7248665B2/ja active Active
- 2018-10-05 FI FIEP18795809.5T patent/FI3692040T3/fi active
- 2018-10-05 DK DK18795809.5T patent/DK3692040T3/da active
- 2018-10-05 RS RS20230207A patent/RS64043B1/sr unknown
- 2018-10-05 AU AU2018344926A patent/AU2018344926A1/en not_active Abandoned
- 2018-10-05 EP EP22214773.8A patent/EP4180431A1/en active Pending
- 2018-10-05 BR BR112020006456-4A patent/BR112020006456A2/pt unknown
- 2018-10-05 HU HUE18795809A patent/HUE061380T2/hu unknown
- 2018-10-05 PT PT187958095T patent/PT3692040T/pt unknown
- 2018-10-05 PL PL18795809.5T patent/PL3692040T3/pl unknown
- 2018-10-05 CA CA3078312A patent/CA3078312A1/en active Pending
- 2018-10-05 US US16/753,645 patent/US20200255428A1/en not_active Abandoned
- 2018-10-05 SG SG10202111648YA patent/SG10202111648YA/en unknown
- 2018-10-05 WO PCT/IB2018/057767 patent/WO2019069293A1/en unknown
- 2018-10-05 SG SG11202002771XA patent/SG11202002771XA/en unknown
- 2018-10-05 LT LTEPPCT/IB2018/057767T patent/LT3692040T/lt unknown
-
2020
- 2020-03-25 PH PH12020550145A patent/PH12020550145A1/en unknown
- 2020-04-02 IL IL273769A patent/IL273769A/en unknown
- 2020-04-03 CL CL2020000912A patent/CL2020000912A1/es unknown
- 2020-04-03 CO CONC2020/0004202A patent/CO2020004202A2/es unknown
-
2021
- 2021-06-04 AU AU2021203650A patent/AU2021203650B9/en active Active
- 2021-10-25 US US17/509,769 patent/US20220144834A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20230274T1 (hr) | Kemijski spojevi | |
| HRP20231018T1 (hr) | Terapeutski spojevi korisni za profilaktičko ili terapijsko liječenje hiv virusne infekcije | |
| HRP20210241T1 (hr) | Derivat policikličkog piridona protiv gripe i njegov predlijek | |
| HRP20211224T1 (hr) | Derivati pirimidina za liječenje virusnih infekcija | |
| HRP20201812T1 (hr) | Modulatori proteina jezgre hepatitisa b | |
| HRP20171512T1 (hr) | Derivati betulina | |
| HRP20161379T1 (hr) | Inhibitori hepatitis c virusa | |
| HRP20211278T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
| HRP20220759T1 (hr) | Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti | |
| WO2017083304A8 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
| HRP20201645T1 (hr) | Triterpenoidi s aktivnošću inhibiranja zrenja hiv, supstituirani na položaju 3 nearomatskim prstenom koji nosi halogenalkilni supstituent | |
| JP2016006053A5 (hr) | ||
| HRP20211223T1 (hr) | Heterociklički indoli za upotrebu kod infekcije virusom influence | |
| JP2016106149A5 (hr) | ||
| EA201791872A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| EA201791019A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| EP3954679A3 (en) | Amide compounds for the treatment of hiv infections | |
| PH12020551709A1 (en) | Antiviral immunotropic agent for the treatment of acute respiratory viral infections | |
| MX2017010506A (es) | Nuevo derivado de quinoleina para usarse en el tratamiento y prevencion de infecciones virales. | |
| HRP20211749T1 (hr) | Pentanske kiseline supstituirane pirolo-[2-3,b]pirimidin-piridinima za liječenje virusnih infekcija influencom | |
| HRP20220683T1 (hr) | Liječenje parkinsonove bolesti | |
| JP2016513703A5 (hr) | ||
| HRP20230935T1 (hr) | Postupci za liječenje i profilaksu hiv-a i aids-a |